AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · IEX Real-Time Price · USD
2.770
-0.010 (-0.36%)
At close: Jul 2, 2024, 4:00 PM
2.780
+0.010 (0.36%)
After-hours: Jul 2, 2024, 7:09 PM EDT
AbCellera Biologics Employees
AbCellera Biologics had 586 employees as of December 31, 2023. The number of employees increased by 91 or 18.38% compared to the previous year.
Employees
586
Change (1Y)
91
Growth (1Y)
18.38%
Revenue / Employee
$61,072
Profits / Employee
-$250,679
Market Cap
814.53M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 586 | 91 | 18.38% |
Dec 31, 2022 | 495 | 109 | 28.24% |
Dec 31, 2021 | 386 | 180 | 87.38% |
Dec 31, 2020 | 206 | 99 | 92.52% |
Dec 31, 2019 | 107 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
ABCL News
- 7 days ago - AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 - Business Wire
- 5 weeks ago - AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 - Business Wire
- 2 months ago - AbCellera Reports Q1 2024 Business Results - Business Wire
- 2 months ago - AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies - Business Wire
- 3 months ago - AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 - Business Wire
- 3 months ago - AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 - Business Wire
- 3 months ago - AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 - Business Wire
- 4 months ago - AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions - Business Wire